Literature DB >> 12040693

Multi-state models for bone marrow transplantation studies.

John P Klein1, Youyi Shu.   

Abstract

High-dose chemotherapy followed by stem cell recovery, more commonly called a bone marrow transplant, is a common treatment for a number of diseases. This article examines four problems commonly encountered when dealing with bone marrow transplant studies. First, we look at the problem of competing causes of failure and at methods based on a multi-state model to estimate meaningful probabilities for these risks. Second, we examine methods for estimating the prevalence of an intermediate condition, here the prevalence of chronic GVHD. Third, we look at the problem of modeling the post transplant recovery process and we provide two examples of how these estimates can be used to assess dynamically a patient's prognosis or how these probabilities can be used to design trials of new therapy. Finally, we present an estimate of a new measure of treatment efficiency, the current leukemia free survival function, which is derived from a multi-state model approach.

Entities:  

Mesh:

Year:  2002        PMID: 12040693     DOI: 10.1191/0962280202sm277ra

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  23 in total

1.  Nonparametric multistate representations of survival and longitudinal data with measurement error.

Authors:  Bo Hu; Liang Li; Xiaofeng Wang; Tom Greene
Journal:  Stat Med       Date:  2012-04-26       Impact factor: 2.373

2.  Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.

Authors:  Christopher G Kanakry; Javier Bolaños-Meade; Yvette L Kasamon; Marianna Zahurak; Nadira Durakovic; Terry Furlong; Marco Mielcarek; Marta Medeot; Ivana Gojo; B Douglas Smith; Jennifer A Kanakry; Ivan M Borrello; Robert A Brodsky; Douglas E Gladstone; Carol Ann Huff; William H Matsui; Lode J Swinnen; Kenneth R Cooke; Richard F Ambinder; Ephraim J Fuchs; Marcos J de Lima; Borje S Andersson; Ravi Varadhan; Paul V O'Donnell; Richard J Jones; Leo Luznik
Journal:  Blood       Date:  2017-01-03       Impact factor: 22.113

Review 3.  Inference for outcome probabilities in multi-state models.

Authors:  Per Kragh Andersen; Maja Pohar Perme
Journal:  Lifetime Data Anal       Date:  2008-09-13       Impact factor: 1.588

Review 4.  Estimation and assessment of markov multistate models with intermittent observations on individuals.

Authors:  J F Lawless; N Nazeri Rad
Journal:  Lifetime Data Anal       Date:  2014-10-21       Impact factor: 1.588

5.  A model-informed rank test for right-censored data with intermediate states.

Authors:  Ritesh Ramchandani; Dianne M Finkelstein; David A Schoenfeld
Journal:  Stat Med       Date:  2015-01-13       Impact factor: 2.373

6.  Assessing Noninferiority in Treatment Trials for Severe Infectious Diseases: an Extension to the Entire Follow-Up Period Using a Cure-Death Multistate Model.

Authors:  Harriet Sommer; Tobias Bluhmki; Jan Beyersmann; Martin Schumacher
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

7.  A new approach to regression analysis of censored competing-risks data.

Authors:  Yuxue Jin; Tze Leung Lai
Journal:  Lifetime Data Anal       Date:  2016-08-08       Impact factor: 1.588

8.  An ensemble survival model for estimating relative residual longevity following stroke: Application to mortality data in the chronic dialysis population.

Authors:  Milind A Phadnis; James B Wetmore; Theresa I Shireman; Edward F Ellerbeck; Jonathan D Mahnken
Journal:  Stat Methods Med Res       Date:  2015-09-24       Impact factor: 3.021

9.  Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion.

Authors:  Matthias Eefting; Liesbeth C de Wreede; Constantijn J M Halkes; Peter A von dem Borne; Sabina Kersting; Erik W A Marijt; Hendrik Veelken; Hein Putter; Johannes Schetelig; J H Frederik Falkenburg
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

10.  Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data.

Authors:  Hans C van Houwelingen; Hein Putter
Journal:  Lifetime Data Anal       Date:  2008-10-03       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.